Ovid Therapeutics Inc.
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the …
Biotechnology
US, New York [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Ovid Therapeutics Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDOvid Therapeutics Inc. can't present revenue by segment